• First CaPP3 Recruit

    First CaPP3 Recruit

    Nick James, our first CaPP3 participant, was recruited in Newcastle by Professor Sir John Burn on 1st October 2014.

  • CaPP3 Study Day

    CaPP3 Study Day

    A meeting to facilitate the clinical study approval process for the CaPP3 Study held on Wednesday 26th February 2014 at Centre Point, London

  • CaPP3 is go!

    CaPP3 is go!

    Now that we have the result of the CAPP2 study which shows that regular aspirin significantly reduces cancer risk in Lynch syndrome, we now need to try and work out the best dose.

Previous Next

Latest News

  • 13

    Oct

    2014

    CaPP3 Study opens to recruitment

    posted on Monday, 13th October 2014
    CaPP3 Study opens to recruitment

    The CaPP3 study opened to recruitment at the Institute of Genetic Medicine, Newcastle on Wednesday 1st October 2014. Professor Sir John Burn consented the first recruit.

    Not tagged.

    Comments (0)

  • 05

    Jun

    2014

    Does your family have the rogue bowel cancer gene?

    posted on Thursday, 5th June 2014

    LYNCH syndrome is deadly but new tests and treatment could help identify and beat it, says campaigner and bowel cancer survivor Lynn Faulds Wood.

    Not tagged.

    Comments (0)

Downloads & Links